Lutein may suppress inflammation

A study measuring the levels of the six most common carotenoids in blood from 193 patients with coronary artery disease has found that lutein was the only carotenoid whose level was correlated with the inflammatory marker interleukin-6, IL-6. The higher the level of lutein in the blood, the lower the level of IL-6.

Cells taken from blood from patients with coronary artery disease confirmed that the inflammatory activity of the cells became significantly lower when they were treated with lutein.

Lutein is found in several highly coloured vegetables and fruits, and is particularly rich in vegetables with dark-green leaves, such as spinach.

https://www.eurekalert.org/pub_releases/2017-07/lu-vca070517.php

Chung, Rosanna W.S., Leanderson, Per, Lundberg, Anna K, Jonasson, Lena. 2017. Lutein exerts anti-inflammatory effects in patients with coronary artery disease. Atherosclerosis, 262, 87-93, published online 6 May 2017, doi: 10.1016/j.atherosclerosis.2017.05.008

Related News

Following on from studies showing that a Mediterranean-like diet may be associated with a lower risk of Alzheimer's disease and may lengthen survival in people with Alzheimer's, a six-year study of 712 New Yorkers has revealed that those who were most closely following a Mediterranean-like diet

An analysis technique using artificial neural networks has revealed that the most important factors for predicting whether amnestic mild cognitive impairment (

A study involving 733 participants from the Framingham Heart Study Offspring Cohort (average age 60) provides more evidence that excess abdominal fat places otherwise healthy, middle-aged people at greater risk for dementia later in life.

A variant of a gene called the fat mass and obesity associated (FTO) gene causes people to gain weight and puts them at risk for obesity. The gene variant is found in nearly half of all people in the U.S. with European ancestry, around one-quarter of U.S.

The largest ever trial of fish oil supplements has found no evidence that they offer benefits for cognitive function in older people. The British study enrolled 867 participants aged 70-80 years, and lasted two years.

Pages

Subscribe to Latest newsSubscribe to Latest newsSubscribe to Latest health newsSubscribe to Latest news